心房颤动伴长间歇的治疗策略：共识与争议

doi:10.12114/j.issn.1007-9572.2023.0826

摘要/Abstract

摘要： 心房颤动（房颤）是心血管疾病中最为常见的心律失常，其常与病态窦房结综合征并存且相互作用。既往临床上对于有症状的房颤伴长间歇治疗多倾向于植入心脏起搏器联合抗心律失常药物，但近年来越来越多的研究表明，与植入起搏器相比，射频消融能降低房性心动过速相关心律失常的住院率、有效控制房颤，改善患者预后及心力衰竭住院率。但同时部分患者存在固有窦房结功能障碍（SND），且SND可在部分患有房颤的患者中逐渐进展及加重。因此，房颤伴长间歇患者的一线治疗策略仍存在争议。本文以房颤伴长间歇治疗策略的选择进行综述。

关键词: 心房颤动, 病窦综合征, 窦性停搏，心脏, 心脏起搏器，人工, 消融技术

Abstract:

Atrial fibrillation (AF) is the most common arrhythmia in cardiovascular disease, and it often coexists and interacts with sick sinus syndrome. In the past, pacemaker implantation combined with antiarrhythmic drugs was preferred for symptomatic atrial fibrillation with long interval treatment. However, in recent years, more and more studies have shown that compared with pacemaker implantation, radiofrequency ablation can reduce the hospitalization rate related to tachycardia, effectively control atrial fibrillation, and improve patient prognosis and hospitalization rate of heart failure. However, some patients present intrinsic sinus node dysfunction (SND), and SND may progress and worsen in some patients with atrial fibrillation. Therefore, the first-line treatment strategy for patients with atrial fibrillation with long interval remains controversial. This article reviews the selection of long-term intermittent treatment strategies for atrial fibrillation.

Key words: Atrial fibrillation, Sick sinus syndrome, Sinus arrest, cardiac, Pacemaker, artificial, Ablation techniques

王潇睿,郑若瑶,孙凤志,等. 心房颤动伴长间歇的治疗策略：共识与争议[J]. 中国全科医学, 2024, 27(27): 3331-3335. DOI: 10.12114/j.issn.1007-9572.2023.0826.
WANG Xiaorui,ZHENG Ruoyao,SUN Fengzhi, et al. Treatment Strategies for Atrial Fibrillation with Long Interval: Consensus and Controversy[J]. Chinese General Practice, 2024, 27(27): 3331-3335. DOI: 10.12114/j.issn.1007-9572.2023.0826.

参考文献 39

[1]	LIPPI G，SANCHIS-GOMAR F，CERVELLIN G. Global epidemiology of atrial fibrillation：an increasing epidemic and public health challenge[J]. Int J Stroke，2021，16（2）：217-221. DOI：10.1177/1747493019897870.
[2]	TSE G，LIU T，LI K H，et al. Tachycardia-bradycardia syndrome：Electrophysiological mechanisms and future therapeutic approaches （Review）[J]. Int J Mol Med，2017，39（3）：519-526. DOI：10.3892/ijmm.2017.2877.
[3]	YANG P S，KIM D，JANG E，et al. Risk of sick sinus syndrome in patients diagnosed with atrial fibrillation：a population-based cohort[J]. J Cardiovasc Electrophysiol，2021，32（10）：2704-2714. DOI：10.1111/jce.15202.
[4]	LIU Y，ZHENG Y，TSE G，et al. Association between sick sinus syndrome and atrial fibrillation：a systematic review and meta-analysis[J]. Int J Cardiol，2023，381：20-36. DOI：10.1016/j.ijcard.2023.03.066.
[5]	IWASAKI Y K，NISHIDA K，KATO T，et al. Atrial fibrillation pathophysiology：implications for management[J]. Circulation，2011，124（20）：2264-2274. DOI：10.1161/CIRCULATIONAHA.111.019893.
[6]	CHANG H Y，LIN Y J，LO L W，et al. Sinus node dysfunction in atrial fibrillation patients：the evidence of regional atrial substrate remodelling [J]. Europace，2013，15（2）：205-211. DOI：10.1093/europace/eus219.
[7]	KNÖLL R，ARRAS M，ZIMMERMANN R，et al. Changes in gene expression following short coronary occlusions studied in porcine hearts with Run-on assays[J]. Cardiovasc Res，1994，28（7）：1062-1069. DOI：10.1093/cvr/28.7.1062.
[8]	TAKLA M，EDLING C E，ZHANG K，et al. Transcriptional profiles of genes related to electrophysiological function in Scn5a+ /- murine hearts[J]. Physiol Rep，2021，9（19）：e15043. DOI：10.14814/phy2.15043.
[9]	ISHIKAWA T，OHNO S，MURAKAMI T，et al. Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction[J]. Heart Rhythm，2017，14（5）：717-724. DOI：10.1016/j.hrthm.2017.01.020.
[10]	THOROLFSDOTTIR R B，SVEINBJORNSSON G，AEGISDOTTIR H M，et al. Genetic insight into sick sinus syndrome[J]. Eur Heart J，2021，42（20）：1959-1971. DOI：10.1093/eurheartj/ehaa1108.
[11]	WOLF R M，GLYNN P，HASHEMI S，et al. Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome：a computational analysis[J]. Am J Physiol Heart Circ Physiol，2013，304（9）：H1253-H1266. DOI：10.1152/ajpheart.00734.2012.
[12]	EPSTEIN A E，DIMARCO J P，ELLENBOGEN K A，et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities：a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. Circulation，2013，127（3）：e283-352. DOI：10.1161/CIR.0b013e318276ce9b.
[13]	NAQVI T Z，CHAO C J. Adverse effects of right ventricular pacing on cardiac function：prevalence，prevention and treatment with physiologic pacing[J]. Trends Cardiovasc Med，2023，33（2）：109-122. DOI：10.1016/j.tcm.2021.10.013.
[14]	DESILVEY D L. Minimizing ventricular pacing to reduce atrial fibrillation in sinus node disease[J]. Am J Geriatr Cardiol，2008，17（1）：57-58. DOI：10.1111/j.1076-7460.2007.07671.x.
[15]	PENG X Y，CHEN Y，WANG X F，et al. Safety and efficacy of His-bundle pacing/left bundle branch area pacing versus right ventricular pacing：a systematic review and meta-analysis[J]. J Interv Card Electrophysiol，2021，62（3）：445-459. DOI：10.1007/s10840-021-00998-w.
[16]	DESHMUKH P，CASAVANT D A，ROMANYSHYN M，et al. Permanent，direct His-bundle pacing：a novel approach to cardiac pacing in patients with normal His-Purkinje activation[J]. Circulation，2000，101（8）：869-877. DOI：10.1161/01.cir.101.8.869.
[17]	GIANNI P，FRANCESCO Z，ENRICO B，et al. The risk of atrial fibrillation during right ventricular pacing[J]. Europace，2016，18（3）：353-358. DOI：10.1093/europace/euv268.
[18]	RAVI V，BEER D，PIETRASIK G M，et al. Development of new-onset or progressive atrial fibrillation in patients with permanent HIS bundle pacing versus right ventricular pacing：results from the RUSH HBP registry[J]. J Am Heart Assoc，2020，9（22）：e018478. DOI：10.1161/JAHA.120.018478.
[19]	HUANG W J，SU L，WU S J，et al. A novel pacing strategy with low and stable output：pacing the left bundle branch immediately beyond the conduction block[J]. Can J Cardiol，2017，33（12）：1736.e1-1736.e3. DOI：10.1016/j.cjca.2017.09.013.
[20]	ZHU H，LI X，WANG Z，et al. New-onset atrial fibrillation following left bundle branch area pacing vs. right ventricular pacing：a two-centre prospective cohort study [J]. Europace，2023，25（1）：121-129. DOI：10.1093/europace/euac132.
[21]	于洋，张烁，王帆，等. 不同部位心房起搏对植入双腔起搏器患者术后发生心房颤动的影响[J]. 中国动脉硬化杂志，2022，30（8）：709-713，724. DOI：10.20039/j.cnki.1007-3949.2022.08.010.
[22]	SUMIYOSHI H，TASAKA H，YOSHIDA K，et al. Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome[J]. J Arrhythm，2023，39（4）：566-573. DOI：10.1002/joa3.12888.
[23]	BUTT M U，OKUMUS N，JABRI A，et al. Early versus late catheter ablation of atrial fibrillation and risk of permanent pacemaker implantation in patients with underlying sinus node dysfunction[J]. J Am Heart Assoc，2022，11（17）：e023333. DOI：10.1161/JAHA.121.023333.
[24]	HSU J C，BIRNIE D，STADLER R W，et al. Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing：a real-world analysis of 37，450 patients followed by remote monitoring[J]. Heart Rhythm，2019，16（7）：983-989. DOI：10.1016/j.hrthm.2019.05.012.
[25]	PUJOL-LÓPEZ M，SAN ANTONIO R，TOLOSANA J M，et al. Programming pacemakers to reduce and terminate atrial fibrillation[J]. Curr Cardiol Rep，2019，21（10）：127. DOI：10.1007/s11886-019-1214-9.
[26]	HOCINI M，SANDERS P，DEISENHOFER I，et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses[J]. Circulation，2003，108（10）：1172-1175. DOI：10.1161/01.CIR.0000090685.13169.07.
[27]	CHEN Y W，BAI R，LIN T，et al. Pacing or ablation：which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome?[J]. Pacing Clin Electrophysiol，2014，37（4）：403-411. DOI：10.1111/pace.12340.
[28]	ZHANG R F，WANG Y，YANG M H，et al. Risk stratification for atrial fibrillation and outcomes in tachycardia-bradycardia syndrome：ablation vs. pacing[J]. Front Cardiovasc Med，2021，8：674471. DOI：10.3389/fcvm.2021.674471.
[29]	侯月梅，王洪斌，周祁娜. 干预心脏自主神经治疗心房颤动的思考[J]. 中国心脏起搏与心电生理杂志，2011，25（3）：192-193. DOI：10.13333/j.cnki.cjcpe.2011.03.005.
[30]	KUSAYAMA T，WAN J Y，YUAN Y，et al. Neural mechanisms and therapeutic opportunities for atrial fibrillation[J]. Methodist Debakey Cardiovasc J，2021，17（1）：43-47. DOI：10.14797/FVDN2224.
[31]	STAVRAKIS S，STONER J A，HUMPHREY M B，et al. TREAT AF （transcutaneous electrical vagus nerve stimulation to suppress atrial fibrillation）：a randomized clinical trial[J]. JACC Clin Electrophysiol，2020，6（3）：282-291. DOI：10.1016/j.jacep.2019.11.008.
[32]	IKEDA S，NOGAMI A，INOUE K，et al. Closed-loop stimulation as a physiological rate-modulated pacing approach based on intracardiac impedance to lower the atrial tachyarrhythmia burden in patients with sinus node dysfunction and atrial fibrillation[J]. J Cardiovasc Electrophysiol，2020，31（5）：1187-1194. DOI：10.1111/jce.14430.
[33]	KIM D H，CHOI J I，LEE K N，et al. Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome：a long pause predicts implantation of a permanent pacemaker[J]. BMC Cardiovasc Disord，2018，18（1）：106. DOI：10.1186/s12872-018-0834-0.
[34]	GUICHARD J B，NAUD P，XIONG F，et al. Comparison of atrial remodeling caused by sustained atrial flutter versus atrial fibrillation[J]. J Am Coll Cardiol，2020，76（4）：374-388. DOI：10.1016/j.jacc.2020.05.062.
[35]	LIN Y S，GUO G B，CHEN Y L，et al. Atrial size independently correlates with the development of paroxysmal atrial fibrillation in patients with sick sinus syndrome[J]. Chang Gung Med J，2010，33（6）：659-667.
[36]	RIESENHUBER M，SPANNBAUER A，RAUSCHA F，et al. Sex differences and long-term outcome in patients with pacemakers[J]. Front Cardiovasc Med，2020，7：569060. DOI：10.3389/fcvm.2020.569060.
[37]	ALBONI P，BAGGIONI G F，SCARFÒ S，et al. Role of sinus node artery disease in sick sinus syndrome in inferior wall acute myocardial infarction[J]. Am J Cardiol，1991，67（15）：1180-1184. DOI：10.1016/0002-9149(91)90923-9.
[38]	VERKERK A O，WILDERS R，CORONEL R，et al. Ionic remodeling of sinoatrial node cells by heart failure[J]. Circulation，2003，108（6）：760-766. DOI：10.1161/01.CIR.0000083719.51661.B9.
[39]	KEIICHI I，TEIICHI Y，KEN-ICHI T，et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses：outcome during a 5-year follow-up[J]. Europace，2014，16（2）：208-213. DOI：10.1093/europace/eut159.